FHL2 Silencing Reduces Wnt Signaling and Osteosarcoma Tumorigenesis In Vitro and In Vivo
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
FHL2 Silencing Reduces Wnt Signaling and Osteosarcoma Tumorigenesis In Vitro and In Vivo
Authors
Keywords
-
Journal
PLoS One
Volume 8, Issue 1, Pages e55034
Publisher
Public Library of Science (PLoS)
Online
2013-01-29
DOI
10.1371/journal.pone.0055034
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The role of WNT10B in physiology and disease
- (2011) P. Wend et al. Acta Physiologica
- Wnt5a: its signalling, functions and implication in diseases
- (2011) A. Kikuchi et al. Acta Physiologica
- FHL2 exhibits anti-proliferative and anti-apoptotic activities in liver cancer cells
- (2011) Chor-Fung Ng et al. CANCER LETTERS
- The Wnt signaling pathway: implications for therapy in osteosarcoma
- (2011) Peter McQueen et al. Expert Review of Anticancer Therapy
- FHL2 expression in peritumoural fibroblasts correlates with lymphatic metastasis in sporadic but not in HNPCC-associated colon cancer
- (2011) Lucia Gullotti et al. LABORATORY INVESTIGATION
- High Wnt Signaling Represses the Proapoptotic Proteoglycan syndecan-2 in Osteosarcoma Cells
- (2010) F.-X. Dieudonne et al. CANCER RESEARCH
- FoxO-Mediated Defense against Oxidative Stress in Osteoblasts Is Indispensable for Skeletal Homeostasis in Mice
- (2010) Elena Ambrogini et al. Cell Metabolism
- Four and a half LIM protein 2 (FHL2) negatively regulates the transcription of E-cadherin through interaction with Snail1
- (2010) Wenjing Zhang et al. EUROPEAN JOURNAL OF CANCER
- Deficiency of the LIM-Only Protein FHL2 Reduces Intestinal Tumorigenesis in Apc Mutant Mice
- (2010) Charlotte Labalette et al. PLoS One
- Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in mice
- (2009) Maya Kansara et al. JOURNAL OF CLINICAL INVESTIGATION
- Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling
- (2009) M Enomoto et al. ONCOGENE
- Wnt signaling control of bone cell apoptosis
- (2008) Peter V N Bodine CELL RESEARCH
- Deficiency in the LIM-only protein FHL2 impairs assembly of extracellular matrix proteins
- (2008) Jung Park et al. FASEB JOURNAL
- FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/β-catenin signaling-dependent Runx2 expression
- (2008) Zahia Hamidouche et al. FASEB JOURNAL
- The four-and-a-half-LIM protein 2 (FHL2) is overexpressed in gliomas and associated with oncogenic activities
- (2008) Ming Li et al. GLIA
- Blockade of the RhoA-JNK-c-Jun-MMP2 Cascade by Atorvastatin Reduces Osteosarcoma Cell Invasion
- (2008) Olivia Fromigué et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The LIM-only Protein FHL2 Regulates Cyclin D1 Expression and Cell Proliferation
- (2008) Charlotte Labalette et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Wnt10b induces chemotaxis of osteosarcoma and correlates with reduced survival
- (2008) Kevin Chen et al. PEDIATRIC BLOOD & CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started